Disposition of linezolid in the isolated rat lung after systemic and pulmonary drug delivery

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 1074-1079

  de Jesús Valle, María José ^a   Uranga, Nora Salamanca ^a   López, Francisco Gónzalez ^a   Hurlé, Alfonso Domínguez Gil ^a   Navarro, Amparo Sánchez ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Pulmonary delivery; Pulmonary distribution; Respiratory patterns

Indexed keywords

LINEZOLID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BOLUS INJECTION; BREATHING RATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG LAVAGE; MALE; MEDICAL NEBULIZER; NONHUMAN; PARTITION COEFFICIENT; RAT; TIDAL VOLUME; TRACHEOTOMY; ULTRAVIOLET RADIATION;

ACETAMIDES; ADMINISTRATION, INHALATION; ANIMALS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; LUNG; MALE; OXAZOLIDINONES; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 35449005407     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm306     Document Type: Article

References (23)

1. Moellering RC. Linezolid: The first oxazolidinone antimicrobial. Ann Intern Med 2003; 138: 135-42.
2. Stevens DL, Dotter B, Madaras-Kelly K. A review of linezolid: The first oxazolidinone antibiotic. Expert Rev Anti Infect Ther 2004; 2 51-9.
3. Kollef MH, Rello J, Cammarata, SK et al. Clinical cure and survival in gram-positive ventilator-associated pneumonia: Retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 2004; 30: 388-94.
4. Zurenko GE, Yagi BH, Schaadt RD et al. In vitro activities of U-100592 and U-100766, novel oxazolldinone antibacterial agents. Antimicrob Agents Chemother 1996; 40: 839-45.
5. Zurenko GE, Gibson JK, Shinabarger DL et al. Oxazolidinones: A new class of antibacterials. Curr Opin Pharmacol 2001; 1: 470-6.
6. Fung HB, Kirschenbaum HL, Ojofeitimi BO. Linezolid: An oxazolidinone antimicrobial agent. Clin Ther 2001; 23: 356-91.
7. Gentry-Nielsen MJ, Olsen KM, Preheim LC. Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother 2002; 46: 1345-51.
8. Conte JE, Jr, Golden JA, Kipps J et al. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 2002; 46: 1475-80.
9. Honeybourne D, Tobin C, Jevons G et al. Intrapulmonary penetration of linezolid. J Antimicrob Chemother 2003; 51: 1431-4.
10. Boselli E, Breilh D, Rimmelé T et al. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med 2005; 33: 1529-33.
11. Saralaya D, Peckham DG, Hulme B et al. Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis. J Antimicrob Chemother 2004; 53 325-8.
12. Gerson SL, Kaplan SL, Bruss JB et al. Hematologic effects of linezolid: Summary of clinical experience. Antimicrob Agents Chemother 2002; 46: 2723-6.
13. Nasraway SA, Shorr AF, Kuter DJ. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: Comparative analysis of linezolid and vancomycin use. Clin Infect Dis 2003; 37: 1609-16.
14. Rao N, Ziran BH, Wegener MM et al. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. Clin Infect Dis 2004; 38: 1058-64.
15. Bishop E, Melvani S, Howden BP et al. Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: A proposed protocol for monitoring therapy in complex patients. Antimicrob Agents Chemother 2006; 50: 1599-602.
16. Moss RB. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest 2002; 121: 55-63.
17. Martinez MSM, Gandarillas CIC, Lanao JM et al. Influence of flow rate on the disposition of levofloxacin and netilmicin in the isolated rat lung. Eur J Pharm Sci 2005; 24: 325-32.
18. Li J, Rayner CR, Dixson S et al. Simple method for the assay of linezolid in brain heart infusion broth by higfi-performance liquid chromatography. Biomed Chromatogr 2004; 18: 1-4.
19. Bomer K, Borner E, Lode H. Determination of linezolid in human serum and urine by high-performance liquid chromatography. Int J Antimicrob Agents 2001; 18: 253-8.
20. Peng GW, Stryd RP, Murata S et al. Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography. J Pharm Biomed Anal 1999; 20: 65-73.
21. Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 1978; 6: 547-58.
22. Weiss M. Distribution kinetics in the body and single organs: Moment analysis. In: D'Argenio DZ ed. Advanced Methods of Pharmacokinetics and Pharmacodynamic System Analysis. New York, NY: Plenum Press, 1995; 89-100.
23. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621.